VALDECOXIB

Valdecoxib is a COX2 selective NSAID used for pain and inflammation. Withdrawn due to cardiovascular and skin reaction risks. Side effects include edema, hypertension, GI upset, and serious allergic reactions. Only GMP materials will be supplied, logistics all according to GDP.

SKU: b22ed3f289a1 Category: Tag:

Product Description


Mechanism of Action

VALDECOXIB exhibits a highdimensional biochemical interaction matrix spanning signallingaxis disruption, catalyticdomain modulation, mitochondrialnetwork recalibration, ionflux redistribution, cytoskeletalarchitecture remodelling, membranepotential rebalancing and transcriptionfactor pathway restructuring. Its molecular topology supports interaction with catalytic residues, allosteric regulators, transmembrane helices, nucleotidebinding pockets, redoxbuffer modules and polymeric scaffolding complexes, enabling wideband influence across metabolic, structural, genomic and electrophysiological domains.

Mechanistically, VALDECOXIB may reshape phosphorylation maps across ERK/MAPK/JNK/p38 axes, alter PI3KAKT survivalbias, modulate Gprotein coupling geometry, redistribute Ca²⁺ microdomain waveforms, adjust IP/DAG signalling topology and recalibrate cAMPPKA amplitude. Mitochondrial impacts include ETCcomplex rebalancing, ATP/ADP cycle modulation, ROSthreshold displacement, mitochondrial membranepotential polarity shifts and crossorganelle stress signalling.

HighPrecision

  • Kinomescale interference & catalyticcascade modelling
  • Highresolution docking & conformationalflow prediction
  • UPR/ERstress & autophagy/mitophagy integration networks
  • Full multiomics reconstruction (RNAseq, proteomics, phosphoproteomics, metabolomics)
  • Cytoskeletal forcemapping & polymer turnover dynamics
  • Cellfate modelling: apoptosis, necroptosis, ferroptosis, parthanatos
  • AIdriven SAR/QSAR predictive simulation

Toxicodynamics & Cellular Hazard Spectrum

  • Excessive ROS accumulation & antioxidantbuffer collapse
  • Mitochondrial fragmentation or ETC suppression
  • Hyperdisruption of Na⁺/K⁺/Ca²⁺ ionicgradients
  • Cytoskeletal degradation & membrane-integrity failure
  • Inflammatory masterswitch activation (NF-κB/STAT/IRF)
  • Multiaxis programmed-cell-death induction
  • Epigenetic drift across methylation & acetylation layers

For expert laboratory research only not intended for biological use.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C16H14N2O3S

Molecular Weight

314.4 g/mol

CAS Number

181695-72-7

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Soluble in methanol and ethanol; freely soluble in organic solvents and alkaline (pH=12) aqueous solution

Purity

Purity information is available upon request (COA).

Synonym

Valdecoxib; 181695-72-7; Bextra; 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide; Valdyn

IUPAC/Chemical Name

4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide

InChl Key

LNPDTQAFDNKSHK-UHFFFAOYSA-N

InChl Code

InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)

References

https://pubchem.ncbi.nlm.nih.gov/compound/119607;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download